TC
Tim Chiang Capital One Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Heron Therapeutics
HRTX
$199M
| $1.30 | $6 |
362%
upside
| Overweight |
23 Apr ‘24
1 year ago |
|
2
Jasper Therapeutics
JSPR
$42.1M
| $2.59 | $70 |
2,603%
upside
| Overweight |
11 Aug ‘23
2 years ago |
|
3
Amphastar Pharmaceuticals
AMPH
$1.36B
| $29.33 | $44 |
50%
upside
| Overweight |
29 Jul ‘22
3 years ago |
|
4
KALA BIO
KALA
$98.3M
| $14 | $200 |
1,329%
upside
| Outperform |
30 Mar ‘22
3 years ago |
|
5
Protagonist Therapeutics
PTGX
$3.63B
| $58.36 | $40 |
31%
downside
| Outperform |
11 Oct ‘21
3 years ago |
|
6
SAB Biotherapeutics
SABS
$22.2M
| $2.13 | $18 |
745%
upside
| Outperform |
4 Oct ‘21
3 years ago |
|
7
Perspective Therapeutics
CATX
$250M
| $3.37 | $1.25 |
63%
downside
| Outperform |
14 Sep ‘21
4 years ago |
|
8
Pacira BioSciences
PCRX
$1.18B
| $26.30 | $66 |
151%
upside
| Market Perform |
5 May ‘21
4 years ago |
|
|
9
Amphastar Pharmaceuticals
AMPH
$1.36B
| $29.33 | $23 |
22%
downside
| Market Perform |
9 Jul ‘20
5 years ago |
|
10
Verrica Pharmaceuticals
VRCA
$47.2M
| $5 | $210 |
4,100%
upside
| Outperform |
24 Jun ‘20
5 years ago |
|